Impairment of executive cognitive functioning in males with fragile X-associated tremor/ataxia syndrome

Movement Disorders

Volumn 22, Issue 5, 2007, Pages 645-650

  Grigsby, Jim ^a   Brega, Angela G ^a   Leehey, Maureen A ^b   Goodrich, Glenn K ^a   Jacquemont, Sébastien ^c   Loesch, Danuta Z ^d   Cogswell, Jennifer B ^e   Epstein, Jennifer ^f   Wilson, Rebecca ^f   Jardini, Tristan ^e   Gould, Emma ^d   Bennett, Rachael E ^a   Hessl, David ^e,g   Cohen, Susannah ^e   Cook, Kylee ^e   Tassone, Flora ^g   Hagerman, Paul J ^g   Hagerman, Randi J ^e,h  

^a UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF COLORADO   (United States)

^c LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^d LA TROBE UNIVERSITY   (Australia)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f CHILDREN S HOSPITAL   (United States)

^g UNIVERSITY OF CALIFORNIA   (United States)

^h UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Cognition; Executive cognitive function; Fragile X; Premutation; Trinucleotide repeats

Indexed keywords

FRAGILE X MENTAL RETARDATION 1 PROTEIN; FRAGILE X MENTAL RETARDATION PROTEIN; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; ATAXIA; CLINICAL ARTICLE; COGNITION; COGNITIVE DEFECT; CONTROLLED STUDY; FRAGILE X SYNDROME; GENE MUTATION; GENETIC ANALYSIS; HUMAN; MALE; PRIORITY JOURNAL; TREMOR;

ADULT; AGED; COGNITION DISORDERS; DIAGNOSIS, DIFFERENTIAL; DNA MUTATIONAL ANALYSIS; FRAGILE X MENTAL RETARDATION PROTEIN; FRAGILE X SYNDROME; HUMANS; INTELLIGENCE; MALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; PROBLEM SOLVING; PROMOTER REGIONS (GENETICS); SPINOCEREBELLAR DEGENERATIONS; TREMOR; TRINUCLEOTIDE REPEATS;

EID: 34249088586     PISSN: 08853185     EISSN: 15318257     Source Type: Journal    
DOI: 10.1002/mds.21359     Document Type: Article

References (40)

1. Verkerk AJ, Pieretti M, Sutcliffe JS, et al. Identification of a gene (FMR-1) containing a CGG repeat coincident with a breakpoint cluster region exhibiting length variation in fragile X syndrome. Cell 1991;65:905-914.
2. Hagerman RJ, Leehey M, Heinrichs W, et al. Intention tremor, parkinsonism, and generalized brain atrophy in male carriers of fragile X. Neurology 2001;57:127-130.
3. Hagerman RJ, Leavitt BR, Farzin F, et al. Fragile X-associated tremor/ataxia syndrome (FXTAS) in females with the FMR1 premutation. Am J Hum Genet 2004;74:1051-1056.
4. Jacquemont S, Hagerman RJ, Leehey M, et al. Fragile X premutation tremor/ataxia syndrome: Molecular, clinical, and neuroimaging correlates. Am J Hum Genet 2003;72:869-878.
5. Jacquemont S, Hagerman RJ, Leehey MA, et al. Penetrance of the fragile X-associated tremor/ataxia syndrome in a premutation carrier population: Initial results from a California family-based study. JAMA 2004;291:460-469.
6. Loesch D, Churchyard A, Brotchie P, Marot M, Tassone F. Evidence for, and a spectrum of, neurological involvement in carriers of the fragile X premutation: FXTAS and beyond. Clin Genet 2005;67:412-417.
7. Greco CM, Hagerman RJ, Tassone F, et al. Neuronal intranuclear inclusions in a new cerebellar tremor/ataxia syndrome among fragile X carriers. Brain 2002;125 (Part 8):1760-1771.
8. Greco CM, Berman RF, Martin RM, et al. Neuropathology of fragile X-associated tremor/ataxia syndrome (FXTAS). Brain 2006;129:243-255.
9. Leehey MA, Munhoz RP, Lang AE, et al. The fragile X premutation presenting as essential tremor. Arch Neurol 2003;60:117-121.
10. Brunberg JA, Jacquemont S, Hagerman RJ, et al. Fragile X premutation carriers: characteristic MR imaging findings of adult male patients with progressive cerebellar and cognitive dysfunction. AJNR Am J Neuroradiol 2002;23:1757-1766.
11. Bacalman S, Farzin F, Bourgeois J, et al. Psychiatric phenotype of the fragile X-associated tremor/ataxia syndrome (FXTAS) in males: newly described fronto-subcortical dementia. J Clin Psychiatry 2006;67:87-94.
12. Grigsby J, Brega AG, Jacquemont S, et al. Impairment in the cognitive functioning of men with fragile x tremor-ataxia syndrome (FXTAS). J Neurol Sci 2006;248:227-233.
13. Grigsby J, Leehey M, Jacquemont S, Brunberg J, Hagerman R, Wilson R. Cognitive impairment in a 65-year-old male with fragile X-associated tremor-ataxia syndrome (FXTAS). Cogn Behav Neurol 2006;19:165-171.
14. Peters N, Kamm C, Asmus F, et al. Intrafamilial variability in fragile X-associated tremor/ataxia syndrome. Mov Disord 2006;21:98-102.
15. Wechsler D. WAIS-III: Wechsler Adult Intelligence Scale-III: Administration and scoring manual, 3rd ed. San Antonio, TX: Psychological Corporation; 1997.
16. Grigsby J, Kaye K, Robbins LJ. Reliabilities, norms and factor structure of the Behavioral Dyscontrol Scale. Percept Mot Skills 1992;74:883-892.
17. Kaye K, Grigsby J, Robbins LJ, Korzun B. Prediction of independent functioning and behavior problems in geriatric patients. J Am Geriatr Soc 1990;38:1304-1310.
18. Diesfeldt H. Executive functioning in psychogeriatric patients: scalability and construct validity of the Behavioral Dyscontrol Scale (BDS). Int J Geriatr Psychiatry 2004;19:1065-1073.
19. Suchy Y, Leahy B, Sweet J, Lam C. Behavioral Dyscontrol Scale deficits among traumatic brain injury patients. Part II. Comparison to other measures of executive functioning. Clin Neuropsychol 2003;17:492-506.
20. Spreen O, Benton AL. Neurosensory center comprehensive examination for aphasia (NCCEA), revised ed. Victoria, BC: University of Victoria Neuropsychology Laboratory; 1977.
21. Goodglass H, Kaplan E. The assessment of aphasia and related disorders, 2nd ed. Philadelphia: Lea & Febiger, 1983.
22. Spreen O, Strauss E. A compendium of neuropsychological tests: administration, norms, and commentary, 2nd ed. New York: Oxford University Press, 1998.
23. Smith A. The Symbol Digit Modalities Test: a neuropsychologic test for economic screening of learning and other cerebral disorders. Learn Disord 1968;3:83-91.
24. Tassone F, Hagerman RJ, Loesch D, Lachiewicz A, Taylor A, Hagerman PJ. Elevated levels of FMR1 messenger RNA in carrier males: a new mechanism of involvement in the fragile X syndrome. Am J Hum Genet 2000;66:6-15.
25. Tassone F, Hagerman RJ, Garcia-Arocena D, Khandjian EW, Greco CM, Hagerman PJ. Intranuclear inclusions in neural cells with premutation alleles in fragile X associated tremor/ataxia syndrome [Letter]. J Med Genet 2004;41:e43.
26. Saluto A, Brussino A, Tassone F, et al. An enhanced polymearse chain reaction assay to detect pre- and full mutation alleles of the fragile X mental retardation 1 gene. J Mol Diagn 2005;4:51-54.
27. Matarazzo J. Wechsler's measurement and appraisal of adult intelligence, 5th ed. Baltimore: Williams and Wilkins; 1972.
28. Loesch D, Bui QM, Grigsby J, et al. Effect of the fragile X status categories and the FMRP levels on executive functioning in fragile X males and females. Neuropsychology 2003;17:646-657.
29. Moore CJ, Daly EM, Schmitz N, et al. A neuropsychological investigation of male premutation carriers of fragile X syndrome. Neuropsychologia 2004;42:1934-1947.
30. Bozcat S, Gregory C, Ralph M, Hodges J. Which neuropsychiatric and behavioural features distinguish frontal and temporal variants of frontotemporal dementia from Alzheimer's disease? J Neurol Neurosurg Psychiatry 2000;69:178-186.
31. Kertesz A, McMonagle P, Blair M, Davidson W, Munoz D. The evolution and pathology of frontotemporal dementia. Brain 2005;128:1996-2005.
32. McKhann GM, Albert MS, Grossman M, Miller B, Dickson D, Trojanowski JQ. Clinical and pathological diagnosis of frontotemporal dementia: report of the work group on frontotemporal dementia and pick's disease. Arch Neurol 2001;58:1803-1809.
33. Rosen H, Gorno-Tempini M, Goldman W, et al. Patterns of brain atrophy in frontotemporal dementia and semantic dementia. Neurology 2002;58:198-208.
34. Bürk K, Globas C, Bösch S, et al. Cognitive deficits in spinocerebellar ataxia type 1, 2, and 3. J Neurol 2003;205:207-211.
35. Schelhaas H, van de Warrenburg B. Clinical, psychological, and genetic characteristics of spinocerebellar ataxia type 19 (SCA19). Cerebellum 2005;4:51-54.
36. Bak T, Crawford L, Hearn V, Mathuranath P, Hodges J. Subcortical dementia revisited: similarities and differences in cognitive function between progressive supranuclear palsy (PSP), coarticobasal degeneration (CBD) and multiple system atrophy (MSA). Neurocase 2005;11:268-273.
37. Robbins T, James M, Lange K, Owen A, Quinn N, Marsden C. Cognitive performance in multiple system atrophy. Brain 1992;115:271-291.
38. Hall D, Berry-Kravis E, Jacquemont S, et al. Initial diagnoses given to persons with the fragile X-associated tremor/ataxia syndrome (FXTAS). Neurology 2005;65:299-301.
39. Kamm C, Healy DG, Quinn NP, et al. The fragile X tremor ataxia syndrome in the differential diagnosis of multiple system atrophy: data from the EMSA Study Group. Brain 2005;128:1855-1860.
40. Hessl D, Tassone F, Loesch D, et al. Abnormal elevation of FMR1 mRNA is associated with psychological symptoms in individuals with the fragile X premutation. Am J Med Genet B 2005;193:115-121.